Abstract: The disclosure relates to genetically modified microorganisms of the genus Paenibacillus, for the improvement of phenotypes of plants, for example nitrogen availability for non-leguminous plants. Included are novel strains of the microorganisms, microbial consortia, and agricultural compositions comprising the same. Furthermore, the disclosure teaches methods of utilizing the described microorganisms, microbial consortia, and agricultural compositions comprising the same, in methods for imparting beneficial properties to target plant species. In particular aspects, the disclosure provides methods of increasing desirable plant traits in agronomically important species, for example nitrogen fixation, utilization, regulation, uptake, acquisition, tolerance, and/or processing in plants.

Abstract: An edge seal for sealing an outer surface of a lower electrode assembly configured to support a semiconductor substrate in a plasma processing chamber, the lower electrode assembly including an annular groove defined between a lower member and an upper member of the lower electrode assembly. The edge seal includes an elastomeric band configured to be arranged within the groove, the elastomeric band having an annular upper surface, an annular lower surface, an inner surface, and an outer surface. When the elastomeric band is in an uncompressed state, the outer surface of the elastomeric band is concave. When the upper and lower surfaces are axially compressed at least 1% such that the elastomeric band is in a compressed state, an outward bulging of the outer surface is not greater than a predetermined distance. The predetermined distance corresponds to a maximum outer diameter of the elastomeric band in the uncompressed state.

Abstract: A sanitary product disposal container includes a container housing having a movable housing top cover. A cover hinge assembly allows the top cover to pivot between open and closed positions. Accordingly, a used feminine hygiene product may be placed in the interior space of the container housing in the open position of the housing top cover while minimizing touching the container housing to open the housing top cover. The housing may be selectively opened to facilitate removal of the used feminine hygiene products from the interior space all without exposure to the used products or the escape of unpleasant odors.

Abstract: An inflatable crate assembly includes a base panel, a rear panel, a first side panel, a second side panel, and a top panel, where: the base panel, the rear panel, the first side panel, the second side panel, and the top panel are all formed from a single piece of drop stitch material; an inner wall of the drop stitch material forms at least a portion of an interior surface of the inflatable crate assembly; and an outer wall of the drop stitch material forms at least a portion of an exterior surface of the inflatable crate assembly; and the inflatable crate also includes a drop stitch corner formed between each of the rear panel and the base panel, the first side panel and the base panel, the top panel and the first side panel, and the second side panel and the top panel.

Abstract: A curtain is suitable for use in a hospital, patient facilities or surgical setting. The curtain is slideably attached along a ceiling track. A top edge of the curtain may be attached to the ceiling track by a number of pulleys each of which may be utilized to lower the top edge of curtain to a height which is conveniently accessible to someone standing on the floor of the room to remove and/or replace the curtain. In some embodiments of this invention, the curtain has a top portion joined to a bottom portion by a zipper. The pulleys lower the curtain for someone to easily access the zipper to remove, replace and/or attach the bottom portion from/to the top portion. In other embodiments, the pulleys lower the entire curtain for removal and replacement.

Abstract: A curtain is suitable for use in hospital, patient facilities or surgical settings. The curtain includes a bottom panel removably attached and suspended from a top panel. The top panel maybe suspended from a rail or similar mechanism by suspension means such as hooks or rings. The top panel may comprise a mesh or mesh-like fabric or substance so as to allow air, light, and/or water to pass through. The bottom panel maybe opaque to provide privacy, and maybe flame resistant and/or antibacterial. The bottom panel maybe single-use or disposable, or maybe reusable. The top and bottom panels are joined by a zipper to allow for removal of the bottom panel for washing or replacement. The zipper track has curved portions to allow for easier access to begin the zipping and unzipping process.

Abstract: A curtain is suitable for use in a hospital or patient facilities or in surgical settings. The curtain includes a bottom panel removably attached and suspended from a top panel. The top panel may be suspended from a rail by suspension means such as hooks or rings. The top panel may be a mesh so as to allow air, light, and/or water to pass through. The bottom panel may be opaque to provide privacy. The bottom panel may be single-use or disposable, or may be reusable. The top and bottom panels are joined by a zipper to allow for removal of the bottom panel for washing or replacement. The zipper track has curved portions to allow for easier access to begin the zipping and unzipping process. The curved portions orient the zipper out of the plane of the curtain to allow for easier movement of zipper through the curved portions.

Abstract: A compound having the formula (I) R1-COOH. R1 is an alkyl or alkenyl group having a C7-11 backbone, optionally branched with a C1-6 alkyl group at any C position in the backbone, or a pharmaceutically acceptable salt, amide or ester thereof. The backbone of the alkyl or alkenyl group, and/or the branched alkyl groups, are optionally interrupted by one or more heteroatoms, provided that when R1 is an alkyl group having a C7 backbone, the branching does not consist only of a hexyl group at the a carbon of R1, or only of a methyl group at the ? carbon of R1, or of only single methyl groups at both the ? and ?-1 carbons of R1, and provided that when R1 is an alkyl group having a C8 or C11 backbone, the branching does not consist only of a propyl group at the a carbon of R1.

Abstract: A compound having the formula (I) R1-COOH. R1 is an alkyl or alkenyl group having a C7-11 backbone, optionally branched with a C1-6 alkyl group at any C position in the backbone, or a pharmaceutically acceptable salt, amide or ester thereof. The backbone of the alkyl or alkenyl group, and/or the branched alkyl groups, are optionally interrupted by one or more heteroatoms, provided that when R1 is an alkyl group having a C7 backbone, the branching does not consist only of a hexyl group at the a carbon of R1, or only of a methyl group at the ? carbon of R1, or of only single methyl groups at both the ? and ?-1 carbons of R1, and provided that when R1 is an alkyl group having a C8 or C11 backbone, the branching does not consist only of a propyl group at the a carbon of R1.

Abstract: A compound having the formula (I) R1-COOH. R1 is an alkyl or alkenyl group having a C7-11 backbone, optionally branched with a C1-6 alkyl group at any C position in the backbone, or a pharmaceutically acceptable salt, amide or ester thereof. The backbone of the alkyl or alkenyl group, and/or the branched alkyl groups, are optionally interrupted by one or more heteroatoms, provided that when R1 is an alkyl group having a C7 backbone, the branching does not consist only of a hexyl group at the a carbon of R1, or only of a methyl group at the ? carbon of R1, or of only single methyl groups at both the ? and ?-1 carbons of R1, and provided that when R1 is an alkyl group having a C8 or C11 backbone, the branching does not consist only of a propyl group at the a carbon of R1.

Abstract: A composition comprising a decanoic acid to octanoic acid ratio of 70:30 to 90:10 wt/wt for use in treating epilepsy or controlling epileptic seizures.

Abstract: A compound having the formula (I) R1-COOH. R1 is an alkyl or alkenyl group having a C7-11 backbone, optionally branched with a C1-6 alkyl group at any C position in the backbone, or a pharmaceutically acceptable salt, amide or ester thereof. The backbone of the alkyl or alkenyl group, and/or the branched alkyl groups, are optionally interrupted by one or more heteroatoms, provided that when R1 is an alkyl group having a C7 backbone, the branching does not consist only of a hexyl group at the ? carbon of R1, or only of a methyl group at the ? carbon of R1, or of only single methyl groups at both the ? and ?-1 carbons of R1, and provided that when R1 is an alkyl group having a C8 dor C11 backbone, the branching does not consist only of a propyl group at the ? carbon of R1.

Abstract: Decanoic acid for use in treating epilepsy wherein the decanoic acid is used in combination with perampanel, or a pharmaceutically acceptable salt thereof, or wherein the decanoic acid is used in combination with an AMPA receptor inhibitor that binds to the same AMPA receptor site as perampanel.

Abstract: A compound having the formula (I) R1-COOH. R1 is an alkyl or alkenyl group having a C7-11 backbone, optionally branched with a C1-6 alkyl group at any C position in the backbone, or a pharmaceutically acceptable salt, amide or ester thereof. The backbone of the alkyl or alkenyl group, and/or the branched alkyl groups, are optionally interrupted by one or more heteroatoms, provided that when R1 is an alkyl group having a C7 backbone, the branching does not consist only of a hexyl group at the a carbon of R1, or only of a methyl group at the ? carbon of R1, or of only single methyl groups at both the ? and ?-1 carbons of R1, and provided that when R1 is an alkyl group having a C8 or C11 backbone, the branching does not consist only of a propyl group at the a carbon of R1.

Abstract: A composition comprising a decanoic acid to octanoic acid ratio of 70:30 to 90:10 wt/wt for use in treating epilepsy or controlling epileptic seizures.

Abstract: A compound having the formula (I) R1-COOH wherein R1 is an alkyl or alkenyl group having a C7-11 backbone, optionally branched with a C1-6 alkyl group at any C position in the backbone, or a pharmaceutically acceptable salt, amide or ester thereof, wherein the backbone of the alkyl or alkenyl group, and/or the branched alkyl groups, are optionally interrupted by one or more heteroatoms, provided that when R1 is an alkyl group having a C7 backbone, the branching does not consist only of a hexyl group at the a carbon of R1, or only of a methyl group at the ? carbon of R1, or of only single methyl groups at both the ? and ??1 carbons of R1, and provided that when R1 is an alkyl group having a C8 or C11 backbone, the branching does not consist only of a propyl group at the a carbon of R1, for use in the treatment or prevention of a disease or a biomedical condition selected from seizure-related disorders, bipolar disorders, mania, depression, migraine, attention deficit hyperactivity disorders, latent HIV infecti

Abstract: A device for fixating and/or supporting a wrist and hand of a patient during a radial artery procedure includes a frame. The frame includes a wrist frame member having a wrist support surface to receive the wrist of the patient. The frame includes a hand frame member having a hand support surface to receive the hand of the patient. The hand support member is pivotally connected to the wrist support member. The hand frame member is movable relative to the wrist frame member between a first position to a second position. In the first position, the hand support surface is at a first angle relative to the wrist support surface to hyperextend the wrist to promote access to the artery for the procedure. In the second position, the hand support surface and the wrist support surface are generally aligned to straighten the wrist and promote hemostasis after the procedure.

Abstract: A compound having the formula (I) R1-COOH wherein R1 is an alkyl or alkenyl group having a C7-11 backbone, optionally branched with a C1-6 alkyl group at any C position in the backbone, or a pharmaceutically acceptable salt, amide or ester thereof, wherein the backbone of the alkyl or alkenyl group, and/or the branched alkyl groups, are optionally interrupted by one or more heteroatoms, provided that when R1 is an alkyl group having a C7 backbone, the branching does not consist only of a hexyl group at the a carbon of R1, or only of a methyl group at the ? carbon of R1, or of only single methyl groups at both the ? and ?-1 carbons of R1, and provided that when R1 is an alkyl group having a C8 or C11 backbone, the branching does not consist only of a propyl group at the a carbon of R1, for use in the treatment or prevention of a disease or a biomedical condition selected from seizure-related disorders, bipolar disorders, mania, depression, migraine, attention deficit hyperactivity disorders, latent HIV infecti